Search

everythinglearnresearchcommunity

for

Search:↓

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Certain cancer drugs can cause skin issues like rashes and itching.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib may help treat hair loss in children with alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Gefitinib therapy can cause unusual hair growth on the nose.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.